iShares Nasdaq Biotechnology ETF (IBB)

Add to Watchlists
Create an Alert
118.55 -0.74  -0.62% NASDAQ Sep 21, 20:00 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 1.18% 1.26% 2.46% 79
3M 5.42% 5.60% 6.64% 69
6M 7.27% 7.38% 12.37% 83
YTD 11.19% 11.32% 18.23% 84
1Y 7.68% 7.84% 20.05% 93
3Y 1.69% 1.67% 9.48% 93
5Y 11.31% 11.31% 14.38% 76
10Y 15.75% 15.77% 14.38% 28
As of Sept. 21, 2018. Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.15% 0.15% 0.00%
Stock 99.85% 99.85% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Sept. 20, 2018

IBB Region Exposure

Americas 97.80%
North America 97.80%
Latin America 0.00%
Greater Europe 1.87%
United Kingdom 0.67%
Europe Developed 1.20%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.33%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.33%
Market Classification
% Developed Markets 99.67%
% Emerging Markets 0.33%
As of Sept. 20, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.06%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.92%
Industrials 0.00%
Real Estate 0.00%
Technology 0.02%
Utilities 0.00%
As of Sept. 20, 2018

IBB Stock Market Capitalization

Giant 16.44%
Large 38.86%
Medium 23.95%
Small 17.75%
Micro 3.00%
As of Sept. 20, 2018

IBB Stock Style Exposure

Large Cap Value 21.21%
Large Cap Blend 8.84%
Large Cap Growth 27.62%
Mid Cap Value 0.46%
Mid Cap Blend 3.54%
Mid Cap Growth 20.09%
Small Cap Value 1.00%
Small Cap Blend 3.92%
Small Cap Growth 13.32%
As of Sept. 20, 2018
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
BIIB Biogen Inc 8.45% 345.41 +1.22%
AMGN Amgen Inc 8.31% 205.10 +0.00%
GILD Gilead Sciences Inc 8.08% 75.51 +0.91%
CELG Celgene Corp 7.55% 87.72 -0.66%
ILMN Illumina Inc 6.18% 358.16 +0.52%
REGN Regeneron Pharmaceuticals Inc 4.69% 390.28 +0.78%
VRTX Vertex Pharmaceuticals Inc 4.27% 180.08 -0.24%
ALXN Alexion Pharmaceuticals Inc 3.35% 121.99 -2.10%
MYL Mylan NV 2.41% 38.99 +0.67%
BMRN Biomarin Pharmaceutical Inc 2.14% 97.84 -2.55%
As of Sept. 20, 2018
Advertisement

IBB One Page Reports

IBB Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 2.30 yrs
Amy Whitelaw 0.00 yrs
Diane Hsiung 10.59 yrs
Greg Savage 10.59 yrs
Jennifer Hsui 6.00 yrs
Rachel Aguirre 0.00 yrs

IBB Net Fund Flows

1M -118.29M
3M 68.64M
6M -489.65M
YTD -1.289B
1Y -829.08M
3Y 787.97M
5Y 2.625B
10Y 2.780B
As of Aug. 31, 2018

IBB Risk Info

Beta (5Y) 1.240
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.8743
Historical Sortino (All) 0.6056
30-Day Rolling Volatility 13.61%
Daily Value at Risk (VaR) 1% (All) 4.83%
Monthly Value at Risk (VaR) 1% (All) 19.37%

IBB Fundamentals

Dividend Yield TTM (9-21-18) 0.27%
SEC Yield (4-30-18) 0.13%
Weighted Average PE Ratio 31.34
Weighted Average Price to Sales Ratio 6.594
Weighted Average Price to Book Ratio 5.775
Weighted Median ROE 5.07%
Weighted Median ROA -2.92%
Forecasted Dividend Yield 0.54%
Forecasted PE Ratio 16.90
Forecasted Price to Sales Ratio 5.509
Forecasted Price to Book Ratio 4.145
Number of Holdings 193
As of Sept. 20, 2018

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 13.61%
Forecasted Book Value Growth 13.91%
Forecasted Cash Flow Growth 2.92%
Forecasted Earnings Growth -12.17%
Forecasted Revenue Growth 11.37%
As of Sept. 20, 2018

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Termination Date
Last Annual Report Date 3/31/2018
Last Prospectus Date 6/26/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.